Repligen Corporation RGEN was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $21.16 to $25.11 in the past one-month time frame.
The company has seen no estimate revisions over the past 30 days, while the Zacks Consensus Estimate remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Repligen currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked stock in the Med-Biomed/Gene industry is ANI Pharmaceuticals, Inc. ANIP, which sports a Zacks Rank #1 (Strong Buy).
Is RGEN going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment